136 related articles for article (PubMed ID: 24575533)
1. The 340b drug discount program: oncology's optical illusion.
Eagle D; Buell RL; Vacirca J
Oncology (Williston Park); 2013 Nov; 27(11):1068, 1070, 1072. PubMed ID: 24575533
[No Abstract] [Full Text] [Related]
2. Cost consequences of the 340B drug discount program.
Conti RM; Bach PB
JAMA; 2013 May; 309(19):1995-6. PubMed ID: 23609758
[No Abstract] [Full Text] [Related]
3. Comprehensive Legislative Reform to Protect the Integrity of the 340B Drug Discount Program.
Zeta LM
Food Drug Law J; 2015; 70(4):481-99, i. PubMed ID: 26827389
[TBL] [Abstract][Full Text] [Related]
4. A different view of the 340B program.
Chapman R
Oncology (Williston Park); 2014 Mar; 28(3):178. PubMed ID: 24855722
[No Abstract] [Full Text] [Related]
5. Role of the 340B Drug Discount Program in Recent Cancer Care Trends.
Kantarjian HM; Chapman R
J Oncol Pract; 2015 Jul; 11(4):303-7. PubMed ID: 26036268
[TBL] [Abstract][Full Text] [Related]
6. Oral oncolytics: Part 2--legislation targeting cost & access, and other initiatives to reduce costs.
Mancini R; McBride A; Kruczynski M
Oncology (Williston Park); 2013 Sep; 27(9):865-6, 871. PubMed ID: 24282981
[No Abstract] [Full Text] [Related]
7. Spending by Commercial Insurers on Chemotherapy Based on Site of Care, 2004-2014.
Winn AN; Keating NL; Trogdon JG; Basch EM; Dusetzina SB
JAMA Oncol; 2018 Apr; 4(4):580-581. PubMed ID: 29470578
[TBL] [Abstract][Full Text] [Related]
8. Patient Protection and Affordable Care Act; program integrity: Exchange, SHOP, and eligibility appeals. Final rule.
Centers for Medicare & Medicaid Services (CMS), HHS
Fed Regist; 2013 Aug; 78(169):54069-146. PubMed ID: 23991479
[TBL] [Abstract][Full Text] [Related]
9. 340B Drug Pricing Program Ceiling Price and Manufacturer Civil Monetary Penalties Regulation. Final rule.
Health Resources and Services Administration, Department of Health and Human Services (HHS)
Fed Regist; 2017 Jan; 82(3):1210-30. PubMed ID: 28071875
[TBL] [Abstract][Full Text] [Related]
10. 340B Drug Pricing Program: The Expansion and Its Effect on Cancer Care.
Fauer A; Friese CR
Clin J Oncol Nurs; 2019 Apr; 23(2):217-219. PubMed ID: 30880808
[TBL] [Abstract][Full Text] [Related]
11. The Cancer Journal Article for Theme Issue: The Problem of Cancer Drug Costs.
Collyar DE
Cancer J; 2020; 26(4):292-297. PubMed ID: 32732671
[TBL] [Abstract][Full Text] [Related]
12. PhRMA sues on 340B orphans.
Lee J
Mod Healthc; 2013 Oct; 43(40):17. PubMed ID: 24340726
[No Abstract] [Full Text] [Related]
13. The profit of prestigious cancer care.
Time; 2013 Mar; 181(8):50-5. PubMed ID: 23488062
[No Abstract] [Full Text] [Related]
14. Early implementation of pre-existing condition insurance plans: providing an interim safety net for the uninsurable.
Hall JP; Moore J
Issue Brief (Commonw Fund); 2011 Jun; 6():1-20. PubMed ID: 21678623
[TBL] [Abstract][Full Text] [Related]
15. Patient Protection and Affordable Care Act; establishment of the multi-state plan program for the Affordable Insurance Exchanges.
U.S. Office of Personnel Management
Fed Regist; 2013 Mar; 78(47):15559-96. PubMed ID: 23477001
[TBL] [Abstract][Full Text] [Related]
16. The CLASS Act: is it dead or just sleeping?
Wiener JM
J Aging Soc Policy; 2012; 24(2):118-35. PubMed ID: 22497354
[TBL] [Abstract][Full Text] [Related]
17. Examining the Benefits of the 340b Drug Discount Program.
Gerlach J; McSweeney S; Swearingen A; Coustasse A
Health Care Manag (Frederick); 2018; 37(3):225-231. PubMed ID: 29901471
[TBL] [Abstract][Full Text] [Related]
18. The patient protection and affordable care act: how will it affect private health insurance for cancer patients?
Schwartz K; Claxton G
Cancer J; 2010; 16(6):572-6. PubMed ID: 21131787
[TBL] [Abstract][Full Text] [Related]
19. Notice regarding section 602 of the Veterans Health Care Act of 1992 inclusion of outpatient hospital facilities--PHS. Notice.
Fed Regist; 1994 Jun; 59(107):29300-1. PubMed ID: 10135125
[TBL] [Abstract][Full Text] [Related]
20. Patient Protection and Affordable Care Act; program integrity: exchange, premium stabilization programs, and market standards; amendments to the HHS notice of benefit and payment parameters for 2014. Final rule.
Centers for Medicare & Medicaid Services (CMS), HHS
Fed Regist; 2013 Oct; 78(210):65045-105. PubMed ID: 24175364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
